ADHD biotech Neos Therapeutics sets terms for $60 million IPO - (NASDAQ via NewsPoints Desk)

  • Neos Therapeutics announced plans to raise $60 million in an IPO by offering 4 million shares at a price range of $14 to $16, reported NASDAQ.
  • The late-stage biotechnology develops extended release formulations of attention-deficit hyperactivity disorder therapies.

To read more NewsPoints articles, click here.